BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30471872)

  • 1. NK cells suppress CD8
    Chen T; Zhang T; Liu C; Wang C; Ding S; Shao Z; Fu R
    Cell Immunol; 2019 Jan; 335():6-14. PubMed ID: 30471872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Killer Group 2A Expressed on Both Peripheral CD3
    Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
    J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia.
    Liu C; Li Z; Sheng W; Fu R; Li L; Zhang T; Wu Y; Xing L; Song J; Wang H; Shao Z
    Immunol Invest; 2014; 43(5):491-503. PubMed ID: 24661133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
    Nielsen N; Pascal V; Fasth AE; Sundström Y; Galsgaard ED; Ahern D; Andersen M; Baslund B; Bartels EM; Bliddal H; Feldmann M; Malmström V; Berg L; Spee P; Söderström K
    Immunology; 2014 Aug; 142(4):581-93. PubMed ID: 24673109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
    Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
    Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-experienced T cells promote NK cell activity through trogocytosis of NKG2D and NKp46 ligands.
    Domaica CI; Fuertes MB; Rossi LE; Girart MV; Avila DE; Rabinovich GA; Zwirner NW
    EMBO Rep; 2009 Aug; 10(8):908-15. PubMed ID: 19498463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Expression of Surface Receptors on NK Cells and NKG2D on Immunocytes in Peripheral Blood of Patients with Nasopharyngeal Carcinoma.
    Xu Y; Zhou R; Huang C; Zhang M; Li J; Zong J; Qiu S; Lin S; Chen H; Ye Y; Pan J
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):661-665. PubMed ID: 29580037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
    Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.
    van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H
    Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X; Li CR; Yang J; Wang GB
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of NKG2A inhibitory receptor on circulating NK cells contributes to transfusion-induced immunodepression in patients with β-thalassemia major.
    Zou Y; Song ZX; Lu Y; Liang XL; Yuan Q; Liao SH; Bao JJ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):509-513. PubMed ID: 27465324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
    Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A
    J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of NKG2D haplotypes on the cell-surface expression of NKG2D protein on natural killer and CD8 T cells of peripheral blood among atomic-bomb survivors.
    Imai K; Hayashi T; Yamaoka M; Kajimura J; Yoshida K; Kusunoki Y; Nakachi K
    Hum Immunol; 2012 Jun; 73(6):686-91. PubMed ID: 22507622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activating receptor NKG2D of natural killer cells promotes resistance against enterovirus-mediated inflammatory cardiomyopathy.
    Klingel K; Fabritius C; Sauter M; Göldner K; Stauch D; Kandolf R; Ettischer N; Gahlen S; Schönberger T; Ebner S; Makrigiannis AP; Bélanger S; Diefenbach A; Polić B; Pratschke J; Kotsch K
    J Pathol; 2014 Oct; 234(2):164-77. PubMed ID: 24797160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-Resident Bystander CD8
    Kefalakes H; Horgan XJ; Jung MK; Amanakis G; Kapuria D; Bolte FJ; Kleiner DE; Koh C; Heller T; Rehermann B
    Gastroenterology; 2021 Nov; 161(5):1567-1583.e9. PubMed ID: 34302839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth.
    Hervieu A; Rébé C; Végran F; Chalmin F; Bruchard M; Vabres P; Apetoh L; Ghiringhelli F; Mignot G
    J Invest Dermatol; 2013 Feb; 133(2):499-508. PubMed ID: 22951720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of NK-Activating Receptor-NKp46/NCR1 on NK Cells in Patients with Severe Aplastic Anemia.
    Fu R; Liu H; Zhang J; Liu C; Ding S; Li L; Wang H; Wang G; Song J; Shao Z
    Clin Lab; 2015; 61(9):1221-9. PubMed ID: 26554241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid method for assessment of natural killer cell function after multiple receptor crosslinking.
    Al-Hubeshy ZB; Coleman A; Nelson M; Goodier MR
    J Immunol Methods; 2011 Mar; 366(1-2):52-9. PubMed ID: 21281644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.